Projects
The performance of saliva specimens for the molecular detection of SARS-CoV-2 and a saliva pooling strategy as a diagnostic tool for epidemiological studies in current SARS-CoV-2 pandemic. Ghent University
Nasopharyngeal swabs are recommended for the molecular diagnosis of COVID-19 but offer disadvantages such as dire shortage. Therefore, we aim to validate saliva as an alternative specimen. We further plan to design a saliva pooling strategy as a part of a diagnostic tool for largescale
real-time epidemiological testing. Such strategy will be of value in the management of current pandemic.
SARS-COV-2 Nursing Home study KU Leuven
Major study goals are to access the current seroprevalence of SARS-Cov-2 in nursing home (NH) residents and staff in Belgium with subsequent monthly follow-up of the sero-incidence over a period of 10 months. Our secondary study goal is to gain additional insights on the association between seropositivity, clinical manifestation and COVID-19 disease outcome.
Evaluation of molecular point-of-care Xpert® Xpress SARS-CoV-2 detection implementation in resource limited settings (EXPERT-CoV2). University of Antwerp
Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA). University of Antwerp
Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA). University of Antwerp
Acquired immunity and immunologic aspects of SARS-CoV-2 infection a population of patients and healthcare workers in Multidisciplinary Oncologic Centres. (MOCOR-Study). University of Antwerp
“Design and synthesis of inhibitors of the SARS-CoV-2 main protease based on the 1,2,3-triazole scaffold” KU Leuven
This project is focused towards obtaining new chemical entities with potential application to the pharmacological management of COVID-19 disease, pathology caused by infection with the SARS-CoV2 virus. The rapid worldwide spread of this disease has outlined the high priority of scientific efforts towards the discovery and obtaining of new therapies based on small molecule drugs, complementing the effectiveness of vaccines approved to date. In ...
Assessment and follow-up of SARS-Cov-2 infection in pregnant women and neonates. University of Antwerp
SARS-COV-2 Child study. KU Leuven
Collaboration between Sciensano and KU Leuven about the seroprevalence of SARS-CoV-2 antibodies in school aged children in two regions with difference in prevalence of COVID-19 disease.